Persistent and recurrent skin and soft tissue infections by Staphylococcus aureus: Impact of the small colony-variant (SCV) phenotype and of Panton-Valentine leukocidin (PVL)-positive S. aureus isolates;Chronisch rezidivierende Infektionen der Haut und Weichgewebe durch Staphylococcus aureus: Klinische Bedeutung des Small-colony-variant (SCV)-Phänotyps und von Panton-Valentine-Leukozidin (PVL)-positiven S.-aureus-Isolaten

Hautarzt

Volumn 65, Issue 1, 2014, Pages 15-25

  Becker, K ^a   Kriegeskorte, A ^a   Sunderkotter C ^a   Loffler B ^a   Von Eiff, C ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b PFIZER INC   (United States)

Author keywords

Abscess; Chronic infection; Resistance; Skin infection; Therapy failure

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM ISOLATE; HOST RESISTANCE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; SKIN INFECTION; SMALL COLONY VARIANT; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHRONIC DISEASE; EXOTOXINS; HUMANS; LEUKOCIDINS; RECURRENCE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84893713675     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-013-2636-8     Document Type: Article

References (71)

1. Abele-Horn M, Schupfner B, Emmerling P et al (2000) Persistent wound infection after herniotomy associated with small-colony variants of Staphylococcus aureus. Infection 28:53-54
2. Abu-Qatouseh LF, Chinni SV, Seggewiß J et al (2010) Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype. J Mol Med 88:565-575
3. Baggett HC, Hennessy TW, Leman R et al (2003) An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol 24:397-402
4. Baumert N, Eiff C von, Schaaff F et al (2002) Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist 8:253-260
5. Becker K (2008) Virulenzfaktoren und molekulare Epidemiologie von Staphylococcus aureus - Renaissance eines alten Erregers? Kind Jugendmed 8:73-82
6. Becker K (2013) Staphylokokken. In: Rascher W (Hrsg) Therapie-Handbuch Infektionskrankheiten, 1. (Sonderedition) Aufl. Elsevier, Urban & Fischer, München, S 444-451
7. Becker K, Harmsen D, Mellmann A et al (2004) Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J Clin Microbiol 42:4988-4995
8. Becker K, Laham NA, Fegeler W et al (2006) Fourier-transform infrared spectroscopic analysis is a powerful tool for studying the dynamic changes in Staphylococcus aureus small-colony variants. J Clin Microbiol 44:3274-3278
9. Becker K, Peters G (2009) "Staphylococcaceae", Micrococcaceae und Dermacoccaceae. In: Neumeister B, Geiss HK, Braun RW, Kimmig P (Hrsg) Mikrobiologische Diagnostik. Bakteriologie - Mykologie - Virologie - Parasitologie, 2. Aufl. Thieme, Stuttgart, S 333-351
10. Becker K, Podbielski A, Sunderkötter et al (2013) MiQ 6a/b: Infektionen der Haut und der subkutanen Weichgewebe - Teil I und II. Urban & Fischer (Elsevier), München
11. Becker K, Eiff C von (2011) Staphylococcus, Micrococcus, and other catalase-positive cocci. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH et al (Hrsg) Manual of clinical microbiology, 10. Aufl. ASM press, Washington, DC
12. Bodmann KF, Grabein B, Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (2010) Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2010. Chemother J 19:179-255
13. Bubeck Wardenburg J, Bae T, Otto M et al (2007) Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405-1406
14. Cribier B, Prévost G, Couppie P et al (1992) Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 185:175-180
15. Dryden MS (2010) Complicated skin and soft tissue infection. J Antimicrob Chemother 65(Suppl 3):iii35-iii44
16. Garcia LG, Lemaire S, Kahl BC et al (2012) Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother 56:3700-3711
17. Gillet Y, Issartel B, Vanhems P et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759
18. Holzinger D, Gieldon L, Mysore V et al (2012) Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J Leukoc Biol 92:1069-1081
19. Hörnig-Franz I, Kahl BC, Tebbe W et al (2007) Nekrotisierende Pneumonie mit Staphylococcus aureus (pvl-Gen positiv). Letal verlaufende Pneumonie bei einem 12-jährigen immunkompetenten Mädchen. Monatsschr Kinderheilkd 155:S10-S15
20. Horst SA, Hoerr V, Beineke A et al (2012) A novel mouse model of Staphylococcus aureus chronic osteomyelitis that closely mimics the human infection: an integrated view of disease pathogenesis. Am J Pathol 181:1206-1214
21. Jappe U, Heuck D, Strommenger B et al (2008) Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains. J Invest Dermatol 128:2655-2664
22. Kahl B, Herrmann M, Everding AS et al (1998) Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 177:1023-1029
23. Kahl BC, Duebbers A, Lubritz G et al (2003) Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol 41:4424-4427
24. Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68:981-1003
25. King MD, Humphrey BJ, Wang YF et al (2006) Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144:309-317
26. Kipp F, Becker K, Peters G, Eiff C von (2004) Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J Clin Microbiol 42:1277-1279
27. Kipp F, Kahl BC, Becker K et al (2005) Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants. J Clin Microbiol 43:1956-1959
28. Kobayashi SD, Malachowa N, Whitney AR et al (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204:937-941
29. Kriegeskorte A, König S, Sander G et al (2011) Small colony variants of Staphylococcus aureus reveal distinct protein profiles. Proteomics 11:2476-2490
30. Lannergård J, Eiff C von, Sander G et al (2008) Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob Agents Chemother 52:4017-4022
31. Lemaire S, Olivier A, Van Bambeke F et al (2008) Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics. Antimicrob Agents Chemother 52:2797-2805
32. Lina G, Piémont Y, Godail-Gamot F et al (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128-1132
33. Lipinska U, Hermans K, Meulemans L et al (2011) Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS One 6:e22864
34. Löffler B, Hussain M, Grundmeier M et al (2010) Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6:e1000715
35. Ma X, Chang W, Zhang C et al (2012) Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils. PLoS One 7:e34970
36. Menestrina G, Serra MD, Prévost G (2001) Mode of action of β-barrel pore-forming toxins of the staphylococcal α-hemolysin family. Toxicon 39:1661-1672
37. Miller LS, Cho JS (2011) Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 11:505-518
38. Musher DM, Baughn RE, Templeton GB, Minuth JN (1977) Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J Infect Dis 136:360-369
39. Niemann S, Ehrhardt C, Medina E et al (2012) Combined action of influenza virus and Staphylococcus aureus Panton-Valentine leukocidin provokes severe lung epithelium damage. J Infect Dis 206:1138-1148
40. Nippe N, Varga G, Holzinger D et al (2011) Subcutaneous infection with S. aureus in mice reveals association of resistance with influx of neutrophils and Th2 response. J Invest Dermatol 131:125-132
41. Proctor RA (2008) Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46:584-593
42. Proctor RA, Balwit JM, Vesga O (1994) Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis 3:302-312
43. Proctor RA, Langevelde P van, Kristjansson M et al (1995) Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 20:95-102
44. Proctor RA, Eiff C von, Kahl BC et al (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4:295-305
45. Rutar T, Zwick OM, Cockerham KP, Horton JC (2005) Bilateral blindness from orbital cellulitis caused by community-acquired methicillin-resistant Staphylococcus aureus. Am J Ophthalmol 140:740-742
46. Sachse F, Becker K, Eiff C von et al (2010) Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy 65:1430-1437
47. Sass V, Schneider T, Wilmes M et al (2010) Human β-defensin 3 inhibits cell wall biosynthesis in staphylococci. Infect Immun 78:2793-2800
48. Schaaff F, Bierbaum G, Baumert N et al (2003) Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol 293:427-435
49. Schaumburg F, Köck R, Friedrich AW et al (2011) Population structure of Staphylococcus aureus from remote African Babongo Pygmies. PLoS Negl Trop Dis 5:e1150
50. Schaumburg F, Köck R, Mellmann A et al (2012) Population dynamics among methicillin resistant Staphylococcus aureus in Germany during a 6-year period. J Clin Microbiol 50:3186-3192
51. Schefold JC, Esposito F, Storm C et al (2007) Therapy-refractory Panton Valentine leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report. J Med Case Reports 1:165
52. Seggewiß J, Becker K, Kotte O et al (2006) Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype. J Bacteriol 188:7765-7777
53. Seifert H, Eiff C von, Fätkenheuer G (1999) Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg Infect Dis 5:450-453
54. Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10:427-439
55. Spaan AN, Henry T, Rooijen WJ van et al (2013) The staphylococcal toxin Panton-Valentine leukocidin targets human C5a receptors. Cell Host Microbe 13:584-594
56. Szmigielski S, Prevost G, Monteil H et al (1999) Leukocidal toxins of staphylococci. Zentralbl Bakteriol 289:185-201
57. Tseng CW, Kyme P, Low J et al (2009) Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One 4:e6387
58. Tuchscherr L, Heitmann V, Hussain M et al (2010) Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 202:1031-1040
59. Tuchscherr L, Medina E, Hussain M et al (2011) Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3:129-141
60. Vaudaux P, Francois P, Bisognano C et al (2002) Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun 70:5428-5437
61. Vesga O, Groeschel MC, Otten MF et al (1996) Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 173:739-742
62. Eiff C von, Becker K (2007) Small-colony variants (SCVs) of staphylococci: a role in foreign body-associated infections. Int J Artif Organs 30:778-785
63. Eiff C von, Becker K, Metze D et al (2001) Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease. Clin Infect Dis 32:1643-1647
64. Eiff C von, Bettin D, Proctor RA et al (1997) Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 25:1250-1251
65. Eiff C von, Heilmann C, Proctor RA et al (1997) A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 179:4706-4712
66. Eiff C von, McNamara P, Becker K et al (2006) Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol 188:687-693
67. Eiff C von, Peters G, Becker K (2006) The small colony variant (SCV) concept - the role of staphylococcal SCVs in persistent infections. Injury 37(Suppl 2):S26-S33
68. Wagenlehner FM, Naber KG, Bambl E et al (2007) Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany. J Hosp Infect 67:114-120
69. Wolter DJ, Emerson JC, McNamara S et al (2013) Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis 57:384-391
70. Wright J (1936) Staphylococcal leucocidin (Neisser-Wechsberg type) and antileucocidin. Lancet 227:1002-1005
71. Ziv G, Sompolinsky D (1976) Biological and ecological investigations on thiamineless dwarf-colony variants of Staphylococcus aureus of bovine udder origin. Res Vet Sci 20:281-287